Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AgeX Therapeutics Q4 Sales $27.00K Down From $505.00K YoY

Author: Benzinga Newsdesk | March 29, 2022 04:14pm
AgeX Therapeutics (AMEX:AGE) reported $27.00 thousand in sales this quarter. This is a 94.65 percent decrease over sales of $505.00 thousand the same period last year.

Posted In: AGE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist